510 related articles for article (PubMed ID: 16499139)
1. New strategies for management of oral mucositis in cancer patients.
Peterson DE
J Support Oncol; 2006 Feb; 4(2 Suppl 1):9-13. PubMed ID: 16499139
[TBL] [Abstract][Full Text] [Related]
2. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis.
McDonnell AM; Lenz KL
Ann Pharmacother; 2007 Jan; 41(1):86-94. PubMed ID: 17190850
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of oral mucositis.
Silverman S
J Support Oncol; 2007 Feb; 5(2 Suppl 1):13-21. PubMed ID: 17366929
[TBL] [Abstract][Full Text] [Related]
4. Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.
Radtke ML; Kolesar JM
J Oncol Pharm Pract; 2005 Sep; 11(3):121-5. PubMed ID: 16390600
[TBL] [Abstract][Full Text] [Related]
5. Updated clinical practice guidelines for the prevention and treatment of mucositis.
Keefe DM; Schubert MM; Elting LS; Sonis ST; Epstein JB; Raber-Durlacher JE; Migliorati CA; McGuire DB; Hutchins RD; Peterson DE;
Cancer; 2007 Mar; 109(5):820-31. PubMed ID: 17236223
[TBL] [Abstract][Full Text] [Related]
6. Palifermin: new drug. Prevention of oral mucositis: inappropriate evaluation.
Prescrire Int; 2007 Aug; 16(90):135-8. PubMed ID: 17724832
[TBL] [Abstract][Full Text] [Related]
7. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.
Rubenstein EB; Peterson DE; Schubert M; Keefe D; McGuire D; Epstein J; Elting LS; Fox PC; Cooksley C; Sonis ST; ;
Cancer; 2004 May; 100(9 Suppl):2026-46. PubMed ID: 15108223
[TBL] [Abstract][Full Text] [Related]
8. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
Hensley ML; Hagerty KL; Kewalramani T; Green DM; Meropol NJ; Wasserman TH; Cohen GI; Emami B; Gradishar WJ; Mitchell RB; Thigpen JT; Trotti A; von Hoff D; Schuchter LM
J Clin Oncol; 2009 Jan; 27(1):127-45. PubMed ID: 19018081
[TBL] [Abstract][Full Text] [Related]
9. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
[TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis.
Demarosi F; Bez C; Carrassi A
Minerva Stomatol; 2002 May; 51(5):173-86. PubMed ID: 12070468
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
12. Keratinocyte growth factor.
Athar U; Gentile TC
Expert Opin Biol Ther; 2009 Jun; 9(6):779-87. PubMed ID: 19456212
[TBL] [Abstract][Full Text] [Related]
13. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.
Scully C; Epstein J; Sonis S
Head Neck; 2003 Dec; 25(12):1057-70. PubMed ID: 14648865
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy.
Tejwani A; Wu S; Jia Y; Agulnik M; Millender L; Lacouture ME
Cancer; 2009 Mar; 115(6):1286-99. PubMed ID: 19170238
[TBL] [Abstract][Full Text] [Related]
15. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
Stiff PJ; Emmanouilides C; Bensinger WI; Gentile T; Blazar B; Shea TC; Lu J; Isitt J; Cesano A; Spielberger R
J Clin Oncol; 2006 Nov; 24(33):5186-93. PubMed ID: 16391299
[TBL] [Abstract][Full Text] [Related]
16. Palifermin (Kepivance) for myelotoxic-therapy-related mucositis.
Med Lett Drugs Ther; 2005 Apr; 47(1207):36. PubMed ID: 15843784
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant.
Beaven AW; Shea TC
Drugs Today (Barc); 2007 Jul; 43(7):461-73. PubMed ID: 17728847
[TBL] [Abstract][Full Text] [Related]
18. Palifermin for patients with haematological malignancies: shifting nursing practice from symptom relief to prevention of oral mucositis.
Fliedner M; Baguet B; Blankart J; Davies M; Henriques E; Leather A; Mazur E; Mihály K; Peeters L; Radványiné A; Sedlackova B
Eur J Oncol Nurs; 2007; 11 Suppl 1():S19-26. PubMed ID: 17540295
[TBL] [Abstract][Full Text] [Related]
19. Oral mucositis.
Scully C; Sonis S; Diz PD
Oral Dis; 2006 May; 12(3):229-41. PubMed ID: 16700732
[TBL] [Abstract][Full Text] [Related]
20. Oral mucositis in cancer therapy.
Sonis ST
J Support Oncol; 2004; 2(6 Suppl 3):3-8. PubMed ID: 15605918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
